Paras Biopharmaceuticals Finland Oy Press Releases - EIN Presswire

Published on June 27, 2024 - 05:00 GMT

Paras Biopharmaceuticals’ Innovative Biologics Production Capabilities and Unique Technologies Showcased at BIO USA 2024

PARAS BIOPHARMA FINLAND announces the release of its 1-1 interview with CEO, Dr. Ashesh Kumar, recorded at the recent BIO International Convention in San Diego OULU, FINLAND, June 27, 2024 /⁨EINPresswire.com⁩/ -- Documented by Global Message - a US-based …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on July 12, 2023 - 05:00 GMT

Paras Biopharma Announces Industry leading Scale-up Development & Production Process of an "Onco-Immunology Fc-fusion"

Paras Biopharma extensive efforts have resulted in successful scale-up, optimization & development of a biologically-active onco-immunology, “peptide FC-fusion” OULU, FINLAND, July 12, 2023 /⁨EINPresswire.com⁩/ -- The scale-up of biologic products are …

Distribution channels: Business & Economy, Companies ...

Published on July 4, 2023 - 05:00 GMT

Paras Biopharma (Biologics CDMO) Maximises Recombinant Protein Expression Facilitating Economical Scale-up of Biologics

Biopharma technology development company in the Nordics, maximises recombinant protein expression in its fully-equipped biologics production facility - Finland. OULU, FINLAND, July 4, 2023 /⁨EINPresswire.com⁩/ -- The company is pleased to disclose its …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 18, 2023 - 04:30 GMT

Inc. Magazine includes Paras Biopharma Finland as one of the Top 10 Most Innovative Biotech Companies to Follow in 2023

OULU, FINLAND, May 18, 2023 /⁨EINPresswire.com⁩/ -- PARAS BIOPHARMA (BIOLOGICS CDMO) FINLAND, a biopharmaceutical technology development company is pleased to be included by Inc. Magazine, USA as “One of the Top 10 Most Innovative Biotech Companies to …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 19, 2022 - 09:00 GMT

Paras Biopharma Creates Excellence with Continuous Biomanufacturing -Achieves objectives of High Productivity Innovation

OULU, FINLAND, December 19, 2022 /⁨EINPresswire.com⁩/ -- With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of Bioproduction technologies for economical production …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on December 12, 2022 - 10:00 GMT

Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”

Paras Biopharmaceuticals revealed the company has streamlined & enhanced its business activities with the establishment of a division called Paras Biologics. OULU, FINLAND, December 12, 2022 /⁨EINPresswire.com⁩/ -- In addition to its existing …

Distribution channels: Business & Economy, Companies ...

Published on November 29, 2022 - 11:00 GMT

Paras Biopharmaceuticals is Highly Recommended for Biologics CDMO – Development, Scale-up & Production

OULU, FINLAND, November 29, 2022 /⁨EINPresswire.com⁩/ -- Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Biopharmaceuticals …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on September 1, 2022 - 05:00 GMT

Paras Biopharmaceuticals Finland identified as one of the Fastest Growing Companies in the Nordic Biotechnology Industry

Company has a strong track record of offering end-to-end Biologics CDMO Services, developing complex biologics, inc development & licensing of biosimilars. OULU, FINLAND, September 1, 2022 /⁨EINPresswire.com⁩/ -- Paras Biopharmaceuticals Finland Oy is …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 3, 2022 - 11:17 GMT

Paras Biopharmaceuticals Finland Oy – Exploring Reverse Merger Opportunity

Paras Biopharmaceuticals Finland Oy is seeking appropriate interest on a Reverse Merger to release its potential. OULU, FINLAND, May 3, 2022 /⁨EINPresswire.com⁩/ -- Paras Biopharmaceuticals Finland Oy with a strong track record of developing a unique …

Distribution channels: Business & Economy, Companies ...

Published on March 29, 2022 - 12:52 GMT

Expansion of Biologics CDMO & Manufacturing Capacity Offerings at Paras Biopharmaceuticals Finland Oy

Pleased to announce that from Q3-2022, company will be in a position to offer an expanded biologics CDMO capacity to European, USA & Canadian groups. OULU, FINLAND, March 29, 2022 /⁨EINPresswire.com⁩/ -- Increased capacity offering comes in the form …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 2, 2022 - 03:00 GMT

Paras Biopharmaceuticals joins the Bioseet Platform, expanding its global outreach of Biosimilar Develop & Partnership

PARAS BIOPHARMACEUTICALS, a Biologics CDMO and complex generics development company in Oulu, Finland is pleased to announce that it has joined Bioseet. OULU, FINLAND, March 2, 2022 /⁨EINPresswire.com⁩/ -- Paras Biopharmaceuticals looks to expand global …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 22, 2022 - 04:00 GMT

Paras Biopharmaceuticals is one of the SUPERFINNS®

PARAS BIOPHARMACEUTICALS a biopharmaceutical technology development company has been selected as one of the SUPERFINN® finalists by Kasvu Open. OULU, OULU, FINLAND, February 22, 2022 /⁨EINPresswire.com⁩/ -- SUPERFINNS® partners selected Paras …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on June 22, 2021 - 02:00 GMT

Paras Biopharmaceuticals Finland Oy named as one of the Top Pharma Outsourcing Companies in Europe 2021

Paras Biopharmaceuticals Highlights Company Innovations that Decode and Create Biologics Medicines for Unmet Medical Needs (Pharma Tech Outlook, USA) OULU, FINLAND, June 22, 2021 /⁨EINPresswire.com⁩/ -- PARAS BIOPHARMACEUTICALS FINLAND OY, a …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on April 28, 2021 - 05:00 GMT

Paras Biopharmaceuticals Finland Oy is named as One of the Top 30 Admired Companies to Watch 2021

Announcement highlights company’s notable development & production of complex biologics, thus providing solutions to make healthcare more cost-efficient. OULU, FINLAND, April 28, 2021 /⁨EINPresswire.com⁩/ -- PARAS BIOPHARMACEUTICALS FINLAND OY, a fast …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 16, 2021 - 07:49 GMT

Paras Biopharmaceuticals Finland Oy affordable healthcare efforts viewed in over 90 countries

Paras Biopharma is a Finland-based microbial biologics company focused on the development of technologies for biosimilars and biologics in an efficient manner. OULU, FINLAND, February 16, 2021 /⁨EINPresswire.com⁩/ -- The overall objective of Paras …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on September 8, 2020 - 03:00 GMT

Paras Biopharma joins PSL Alliance & its global membership to promote worldwide reach out for its Bioprocess Enzymes

Paras Biopharma announces that it is now a member of the Pivotal Scientific Limited (PSL) Alliance, a network of companies operating within the biotech market. OULU, FINLAND, September 8, 2020 /⁨EINPresswire.com⁩/ -- Paras Biopharmaceuticals Finland Oy ( …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on September 10, 2019 - 03:00 GMT

Paras Biopharma Successfully Develops Cytofold StructQuant® Tech for Cytoplasmic Disulphide Formation

Paras Biopharma Successfully Develops Cytofold StructQuant® Tech for Cytoplasmic Disulphide Formation, (for Active Folding) for Complex Therapeutic Proteins OULU, FINLAND, September 10, 2019 /⁨EINPresswire.com⁩/ -- Oulu, Finland – 9th September 2019 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 7, 2019 - 00:00 GMT

Reuters to make documentary on Paras Biopharmaceuticals Finland – Innovations in Biologics: Insights of a leading expert

Paras Biopharmaceuticals is proud to announce that Reuters has selected Finland-based company, working on biologics manufacturing & innovations in healthcare OULU, FINLAND, May 7, 2019 /⁨EINPresswire.com⁩/ -- Paras Biopharmaceuticals Finland Oy is …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...